Skip to main content

Table 4 Five-year relative survival rates according to the stage of diagnosis

From: Population-based study of ovarian cancer in Côte d'Or: prognostic factors and trends in relative survival rates over the last 20 years

Variables

N

Deaths

5-year relative survival rates (95% CI)

Age

   

FIGO I-II

   

< 50

73

20

80.69 (69.09-88.29)

50-70

111

40

79.50 (69.94-86.32)

>=70

61

42

59.88 (43.12-73.15)

FIGO III-IV

   

< 50

78

59

35.83 (25.11-46.65)

50-70

231

192

26.31 (20.59-32.36)

> = 70

155

137

20.70 (13.91-28.44)

Histologic type

   

FIGO I-II

   

Serous

101

44

73.38 (61.98-81.85)

Mucinous-endometroîd

78

31

74.94 (62.74-83.65)

Other epithelials

34

19

65.82 (45.99-79.83)

Non epithelials

32

8

93.79 (67.65-98.95)

FIGO III-IV

   

Serous

315

255

31.11 (25.68-36.68)

Mucinous-endometroîd

82

71

21.36 (12.94-31.19)

Other epithelials

49

48

6.21 (1.41-16.34)

Non epithelials

*

*

*

Period of diagnosis

  

FIGO I-II

   

1982-1989

84

39

73.44 (61.20-82.35)

1990-1997

84

38

75.40 (63.00-84.15)

1998-2005

77

25

80.83 (67.98-88.93)

FIGO III-IV

   

1982-1989

122

110

19.46 (12.53-27.52)

1990-1997

160

145

20.31 (14.24-27.15)

1998-2005

182

133

36.24 (28.68-43.84)

Place of residence

   

FIGO I-II

   

Urban

143

59

75.02 (65.89-82.03)

rural

102

43

77.66 (67.08-85.20)

FIGO III-IV

   

Urban

248

203

28.54 (22.62-34.71)

rural

215

184

23.38 (17.63-29.63)